TOKYO, Jun 05 (Pulse News Wire) – Susmed,inc. (4263.T) announced today that it has achieved a milestone in its sales partnership agreement with Shionogi & Co.
Related to the development progress of its sleep disorder app, Medcle. The milestone was triggered by the successful inclusion of the app in health insurance coverage, among other factors. Details of the financial implications and revenue recognition timing are currently being finalized and will be disclosed promptly once determined. Sales of the Medcle app commenced on June 01, 2026, aimed at patients suffering from insomnia and healthcare professionals involved in their treatment.
SUSMED remains committed to promoting the app's widespread adoption. For background, SUSMED entered into the initial sales partnership agreement with Shionogi & Co. on December 27, 2021. The app received approval for health insurance coverage on May 13, 2026.
🟢 Confidence: High AI-translated content.